Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Nitroglycerine 2.6 mg Tablet
Therapeutic Category
Cardiology, Cardiovascular
Dosage Form
Tablet
Packaging Type
Bottle
Packaging
30 Tablets
Price
₹186/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Nitroglee 2.6 Tablet contains Nitroglycerine 2.6 mg, a vasodilator used primarily in the management of angina pectoris (chest pain). It works by relaxing and widening blood vessels, allowing more oxygen-rich blood to flow to the heart muscle, thereby reducing its workload and relieving chest discomfort. This medication belongs to the nitrate class and is widely used for both the prevention and relief of angina attacks in patients with coronary artery disease.
Common side effects include headache, dizziness, lightheadedness, and a drop in blood pressure. Some patients may also experience flushing, nausea, or palpitations. These effects are often transient but should be monitored, especially during initial dosing or dose adjustments.
Nitroglee 2.6 is indicated for the prevention of angina pectoris due to coronary artery disease. It may also be used as part of the long-term treatment plan for patients with chronic stable angina, helping to improve exercise tolerance and reduce the frequency of chest pain episodes.
This medicine should be used strictly as prescribed. Avoid abrupt discontinuation without consulting a physician. Do not use with phosphodiesterase inhibitors (like sildenafil) due to the risk of severe hypotension. Patients should rise slowly from sitting or lying positions to reduce the risk of dizziness or fainting.
Store at 15°C to 30°C, in a cool and dry place, away from moisture and direct sunlight.
Composition : Nitroglycerine 6.4 mg Tablet
Composition : Nebivolol 2.5 mg Tablet
Composition : Nebivolol 5 mg Tablet
Composition : Labetalol 100 mg
Composition : Fenofibrate 160 mg tablet
Composition : Fenofibrate (145mg) tablet
Composition : Ezetimibe 10 mg tablet
Composition : Torsemide 10mg + Spironolactone 50mg Tablets
Composition : Aspirin 75mg + Rosuvastatin 10mg + Clopidogrel 75mg Tablet
Composition : Aspirin 75 mg + Rosuvastatin 20 mg + Clopidogrel 75 mg capsule
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Nitroglycerine 2.6 mg Tablet is a vasodilator and anti-anginal medication used for the management of chronic stable angina (chest pain), coronary artery disease, and ischemic heart conditions. It works by relaxing and widening blood vessels, improving blood flow to the heart, and reducing cardiac workload. This product is widely prescribed in the cardiology and cardiovascular care segment, making it a strong opportunity for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from cardiologists, physicians, and hospital-based prescribing doctors. As angina and heart-related conditions require long-term management, Nitroglycerine 2.6 mg Tablet ensures regular prescriptions, repeat sales, and stable market demand, supporting strong business growth in the cardiac segment.
Yes, Cafoli Lifecare offers PCD pharma franchise opportunities in the cardiology and cardiovascular care segment with monopoly rights, quality-assured manufacturing standards, strong promotional support, and reliable supply chain assistance for distributors and franchise partners.
Wholesalers and distributors benefit from high prescription stability, long-term patient usage, continuous demand from cardiac care units, and strong institutional procurement, making this product a profitable and sustainable addition to their pharmaceutical portfolio when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in cardiology and anti-anginal formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, promotional support, and PCD pharma franchise opportunities in the cardiovascular segment.